Covered California Delays Vote on Specialty Rx Price Cap
On Thursday, Covered California's board of directors delayed a vote on a new specialty prescription drug price cap for its 2016 health plans. Exchange officials had proposed a $500 monthly cap, but advocates have urged the exchange to adopt a lower cap of $200 per month. The board said it would seek more feedback and potentially vote on the cap next month.
- "Covered California Postpones Vote on Drug-Cost Cap" (Sangree, Sacramento Bee, 4/16).